Myomancy ADHD, Dyslexia and Autism

FDA Approves VYVANSE(TM) (lisdexamfetamine dimesylate), the First … - FOXBusiness


HealthNewsDigest.com
FDA Approves VYVANSE(TM) (lisdexamfetamine dimesylate), the First …
FOXBusiness - 4 hours ago
VYVANSE, introduced in July 2007 for the treatment of ADHD in children aged 6 to 12 years, is now the first and only once-daily prodrug stimulant approved …
ADRs in Focus: Shire rises on expanded Vyvanse approval Forbes
Shire Wins US FDA Approval of Vyvanse Use in Adults (Update1) Bloomberg
Shire Gets FDA approval of Vyvanse for adult use Basingstoke Business News (press release)
Guardian - Forbes
all 41 news articles

Find Out More:

Books:

April 24th, 2008
Vyvanse

Leave a Reply

*Required

Truncated Domes

ADHD Boarding Schools

Pharmaceuticals GMP Procedures

Moving

Child Development

Autism Nutrition and Chelation

Natural ADHD Treatments

Golfshop



Discuss the topics raised by this article on the Myomancy Forum.

Archives


7417 posts since May 2004

Google Search

Search Myomancy for news and information about ADHD, Dyslexia and Autism including diagnosis techniques, treatments and the science behind them.

Myomancy Treatment Database

A comprehensive list of every type of treatment available for ADHD, Autism and Dyslexia reviewed and rated by people who have tried them is available on the Myomancy Treatment Database. It covers mainstream treatments focusing on Reading as well as those less recognised using Biofeedback, Dietry and Rhythm. There are also treatments that deal with specific issues such as Audiotory, Visual, Balance, Coordination, Memory. Some treatments are provided as special centers whilst others are available via Books, CDs, DVDs or Software.

Read the latest on ADHD, Dyslexia and Autism from Myomancy via RSS 2.0 or use FeedBurner: